https://ift.tt/2IVHF6y

The stock dipped 6% to Rs 742 on the BSE after the US health regulator recommended a regulatory or administrative action after the inspection of the drug firm's Roorkee manufacturing facility.

from Markets https://ift.tt/2Edo3rc

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads